PRINCETON, N.J., Jan. 8, 2024 /PRNewswire/ Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an.
Clinical Success Achieved in Second Cohort of Patients
PRINCETON, N.J., Jan. 4, 2024 /PRNewswire/ Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and.
Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease In Nonhuman Primate Models Of Ebola And Marburg Viruses menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
HyBryte™ has potential to address a critical gap in treatment of early-stage CTCL
PRINCETON, N.J., Dec. 1, 2023 /PRNewswire/ Soligenix, Inc. , a late-stage biopharmaceutical company focused on.